https://www.newswise.com/articles/lji-scientists-uncover-the-structure-and-function-of-inmazeb-the-first-fda-approved-drug-for-ebola-virus-infection
0
0
1/30/23 at 9:30pm
Organization
Newswise
Inmazeb (REGN-EB3), developed by Regeneron, is a three-antibody cocktail designed to target the Ebola virus glycoprotein. The drug was first approved for clinic
Create an account
or login to join the discussion